Navigation Links
Abbott Annual Meeting Highlights Continued Strong Performance in 2009; Sustained Growth in 2010
Date:4/23/2010

ABBOTT PARK, Ill., April 23 /PRNewswire-FirstCall/ -- Abbott's (NYSE: ABT) diversified strategy continued to deliver superior growth and performance in 2009, Chairman and Chief Executive Officer Miles D. White told shareholders today at the company's annual meeting.  

"Abbott had another highly productive and successful year in 2009," said Mr. White.  "We delivered strong sales and earnings growth and took strategic actions to reshape our business portfolio for the long term, adding early- and late-stage pipeline technologies as well as new growth platforms."

Value of Diversity

Balanced performance across the company's major businesses and continued strong international growth drove a third consecutive year of double-digit ongoing earnings growth in 2009.  A majority of Abbott revenue was generated outside the U.S. for the third straight year, driven by growth across all businesses and strong performance within emerging markets in Asia, Eastern Europe and Latin America.  

Abbott has been a strong and solid long-term investment – significantly outperforming the major stock indices and the majority of its health care peers over the last three, five and 10 years.  Abbott's top-tier total return is a reflection of Abbott's stock price appreciation and dividend increases.  

"Abbott's diversified strategy has delivered years of superior growth and top-tier performance," said Mr. White.  "We are optimistic about the fundamental performance of our business with double-digit ongoing earning
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
2. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
3. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
4. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
5. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
6. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
7. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
8. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
9. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
10. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Oct. 30, 2014  Misonix, Inc. (NASDAQ: ... designs, manufactures and markets innovative therapeutic ultrasonic instruments for ... that it will report financial results for the first ... The Company has scheduled a conference call that same ... to review the results. Interested parties ...
(Date:10/30/2014)... , Oct. 30, 2014 Boston Scientific ... participate in the 2014 Credit Suisse Annual Healthcare Conference ... , AZ.  Dan Brennan , executive vice ... about the company beginning at approximately 8:00 a.m. PT ... A live webcast of the presentation and question and ...
(Date:10/30/2014)... -- Nektar Therapeutics (Nasdaq: NKTR ) will announce ... 30, 2014 on Thursday, November 6, 2014, after the ... president and chief executive officer, will host a conference ... Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... of the conference call can be accessed through a ...
Breaking Medicine Technology:Misonix, Inc. To Report First Quarter Fiscal Year 2015 Financial Results On Thursday, November 6, 2014 2Boston Scientific To Participate In 2014 Credit Suisse Annual Healthcare Conference 2Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2
... Aug. 20, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: ... leading China-based biotechnology company focused on researching, developing, ... the annual general meeting of shareholders of 3SBio ... at 10:00 a.m., Shenyang time, at our executive ...
... As Medicare expands a controversial "competitive" bidding program for home ... Congress have gone on record to oppose that program citing ... and impact on local jobs. "There,s a reason ... 244 economists and auction experts , and 145 members ...
Cached Medicine Technology:3SBio Inc. to Hold 2011 Annual General Meeting on September 20, 2011 2Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services 2Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services 3Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services 4Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services 5
(Date:10/30/2014)... treatments for injuries and damage to the joints, including ... is a hard material that caps the ends of ... biomedical engineers, exploring ways to toughen up engineered cartilage ... new developments this week in the journal Proceedings ... problem with engineered tissue is that the mechanical properties ...
(Date:10/30/2014)... Nutrition Leaders, a popular online retailer ... and more, is currently hosting a sweepstakes on its ... is open to U.S. residents age 18 and over, ... One lucky winner will then be selected at random ... card to NutritionLeaders.com. , Nutrition Leaders’ managing director Kimba ...
(Date:10/30/2014)... Portland, OR (PRWEB) October 30, 2014 ... law firm Hodgkinson Street LLC announces new branding ... Hodgkinson Street Mepham . After David Mepham’s promotion ... revitalizes their brand and website to include Mepham’s name ... leading medical malpractice and mediation firm, the decision to ...
(Date:10/30/2014)... Tara Haelle ... News) -- More than 100 genes have been identified ... studies report. And researchers say they are on ... that may contribute to the disorder. Autism spectrum ... communication and social difficulties and repetitive behaviors. An estimated ...
(Date:10/30/2014)... 30, 2014 Global prebiotics market is ... to a new study by Grand View Research, Inc. ... for sugar and fat free products owing to increased ... for prebiotics over the forecast period. , View full ... Food & beverage was the largest application segment with ...
Breaking Medicine News(10 mins):Health News:Making lab-grown tissues stronger 2Health News:Nutrition Leaders Announces Gift Card Sweepstakes 2Health News:Hodgkinson Street Mepham Rebrands 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 2Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 4Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 5
... a dangerous heart arrhythmia, study finds , THURSDAY, Dec. ... rapid heartbeat called ventricular tachycardia often get implantable cardiac ... study suggests that they will have fewer recurrences of ... ablation before they receive the device. , Reporting Dec. ...
... , REDMOND, Wash., Dec. 31 It,s a fact: each ... from concerned family members looking for help and answers as to ... assistance. The surge comes post holiday, a time when adult children ... parents and family members. Aegis Living, a national leader in senior ...
... genetic puzzle to try to save the mammals , THURSDAY, ... understanding of an outbreak of cancerous tumors that is killing ... , Devil facial tumor disease, a kind of cancer that,s ... contact, is one of only two types of cancer known ...
... , , WESTON, Fla., Dec. ... (the Company) annual meeting of shareholders on December 28, 2009 ... As there were not sufficient shares present in person or by ... Meeting, the Company adjourned the Annual Meeting in order to permit ...
... boom could strain resources with not just more but sicker ... getting older, and experts say the nation,s health-care system is ... The oldest members of the 78-million-strong baby-boom generation are about ... proportion of U.S. residents older than 65 will double, according ...
... , MISSION, Kan., ... subsidy extension into law on Dec. 19, 2009. With this extension, ... and adjust administrative procedures. To smooth the transition, COBRAGuard Inc. is ... Central Time. The Webinar is entitled, "How to Get it Right ...
Cached Medicine News:Health News:Procedure Boosts Outcomes in Implantable Defibrillator Patients 2Health News:After the Holidays Families Recognize Changing Needs of Aging Parents and Loved Ones 2Health News:After the Holidays Families Recognize Changing Needs of Aging Parents and Loved Ones 3Health News:Clues to Cancer That Could Wipe Out Tasmanian Devils 2Health News:American Scientific Resources 2009 Annual Meeting of Shareholders Adjourned 2Health News:As U.S. Ages, Health Care May Need to Change 2Health News:As U.S. Ages, Health Care May Need to Change 3Health News:COBRAGuard Offers Free Action Plan Webinar to Assist Employers with COBRA Subsidy Extension 2Health News:COBRAGuard Offers Free Action Plan Webinar to Assist Employers with COBRA Subsidy Extension 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: